These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29081474)

  • 1. Cardiovascular and Bleeding Risks in Acute Myocardial Infarction Newly Treated With Ticagrelor vs. Clopidogrel in Taiwan.
    Lee CH; Cheng CL; Kao Yang YH; Chao TH; Chen JY; Li YH
    Circ J; 2018 Feb; 82(3):747-756. PubMed ID: 29081474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De-escalation from ticagrelor to clopidogrel in patients with acute myocardial infarction: the TALOS-AMI HBR substudy.
    Kim MC; Ahn SG; Cho KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Lee JW; Youn YJ; Kim HY; Yoo KD; Jeon DS; Shin ES; Jeong YH; Chang K; Ahn Y
    EuroIntervention; 2023 Dec; 19(10):e832-e843. PubMed ID: 37724337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact of Dyspnea after Ticagrelor Treatment and the Effect of Switching to Clopidogrel in Patients with Myocardial Infarction.
    Kim SH; Shin S; Choo EH; Choi IJ; Lim S; Moon D; Kim CJ; Park MW; Kim MC; Hwang BH; Lee KY; Choi YS; Kim HY; Yoo KD; Jeon DS; Ahn Y; Chang K;
    Thromb Haemost; 2024 Dec; 124(12):1152-1161. PubMed ID: 38574757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of ticagrelor and clopidogrel in patients with acute ST-segment elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials.
    Geravandi M; Nourabi M; Navabifar S; Geravandi M; Hooshanginezhad Z; Zand S; Taheri P
    BMC Pharmacol Toxicol; 2024 Dec; 25(1):93. PubMed ID: 39654024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticagrelor vs Prasugrel for Acute Coronary Syndrome in Routine Care.
    Krüger N; Krefting J; Kessler T; Schmieder R; Starnecker F; Dutsch A; Graesser C; Meyer-Lindemann U; Storz T; Pugach I; Frieß C; Chen Z; Bongiovanni D; Manea I; Dreischulte T; Offenborn F; Krase P; Sager HB; Wiebe J; Kufner S; Xhepa E; Joner M; Trenkwalder T; Gueldener U; Kastrati A; Cassese S; Schunkert H; von Scheidt M;
    JAMA Netw Open; 2024 Dec; 7(12):e2448389. PubMed ID: 39621344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticagrelor monotherapy in ST-elevation myocardial infarction: An individual patient-level meta-analysis from TICO and T-PASS trials.
    Lee YJ; Cho DK; Lee JW; Shin S; Kwon SW; Suh Y; Kang TS; Park JK; Bae JW; Kang WC; Kim S; Lee SJ; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Yun KH; Hong MK
    Med; 2024 Dec; 5(12):1466-1474.e2. PubMed ID: 39153473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of proton pump inhibitor use on clinical outcomes in East Asian patients receiving clopidogrel following drug-eluting stent implantation.
    Kim JH; Hong SJ; Cha JJ; Lim S; Joo HJ; Park JH; Yu CW; Ahn TH; Jeong YH; Kim BK; Chang K; Park Y; Song YB; Ahn SG; Suh JW; Lee SY; Cho JR; Her AY; Kim HS; Kim MH; Shin ES; Lim DS
    BMC Med; 2024 Aug; 22(1):335. PubMed ID: 39148087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial.
    Zhang X; Jing J; Wang A; Xie X; Johnston SC; Li H; Bath PM; Xu Q; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Chen W; Gong X; Li J; Han X; Meng X; Wang Y
    Stroke Vasc Neurol; 2024 Nov; 9(5):541-550. PubMed ID: 38286485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Clinical Outcomes Between Ticagrelor and Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction　- Results From the Korea Acute Myocardial Infarction Registry-National Institutes of Health.
    Kim MC; Jeong MH; Sim DS; Hong YJ; Kim JH; Ahn Y; Ahn TH; Seung KB; Choi DJ; Kim HS; Gwon HC; Seong IW; Hwang KK; Chae SC; Hur SH; Cha KS; Oh SK; Chae JK;
    Circ J; 2018 Jun; 82(7):1866-1873. PubMed ID: 29643279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost effectiveness of genetic testing for CYP2C19 variants to guide thienopyridine treatment in patients with acute coronary syndromes: a New Zealand evaluation.
    Panattoni L; Brown PM; Te Ao B; Webster M; Gladding P
    Pharmacoeconomics; 2012 Nov; 30(11):1067-84. PubMed ID: 22974536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-Analysis.
    Maas DPMSM; Willems LH; Kranendonk J; Kramers C; Warlé MC
    Drugs; 2024 Oct; 84(10):1275-1297. PubMed ID: 39235670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease.
    Redfern J; Tu Q; Hyun K; Hollings MA; Hafiz N; Zwack C; Free C; Perel P; Chow CK
    Cochrane Database Syst Rev; 2024 Mar; 3(3):CD011851. PubMed ID: 38533994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update.
    Angiolillo DJ; Galli M; Alexopoulos D; Aradi D; Bhatt DL; Bonello L; Capodanno D; Cavallari LH; Collet JP; Cuisset T; Ferreiro JL; Franchi F; Geisler T; Gibson CM; Gorog DA; Gurbel PA; Jeong YH; Marcucci R; Siller-Matula JM; Mehran R; Neumann FJ; Pereira NL; Rizas KD; Rollini F; So DYF; Stone GW; Storey RF; Tantry US; Berg JT; Trenk D; Valgimigli M; Waksman R; Sibbing D
    JACC Cardiovasc Interv; 2024 Nov; 17(22):2639-2663. PubMed ID: 39603778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for patients with pilonidal sinus disease: PITSTOP, a mixed-methods evaluation.
    Brown S; Hind D; Strong E; Bradburn M; Din FVN; Lee E; Lee MJ; Lund J; Moffatt C; Morton J; Senapati A; Shackley P; Vaughan-Shaw P; Wysocki AP; Callaghan T; Jones H; Wickramasekera N;
    Health Technol Assess; 2024 Jul; 28(33):1-113. PubMed ID: 39045854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial.
    Chowdary P; Angchaisuksiri P; Apte S; Astermark J; Benson G; Chan AKC; Jiménez Yuste V; Matsushita T; Høgh Nielsen AR; Sathar J; Sutton C; Šaulytė Trakymienė S; Tran H; Villarreal Martinez L; Wheeler AP; Windyga J; Young G; Thaung Zaw JJ; Eichler H
    Lancet Haematol; 2024 Dec; 11(12):e891-e904. PubMed ID: 39521008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis.
    Carvalho PEP; Gewehr DM; Nascimento BR; Melo L; Burkhardt G; Rivera A; Braga MAP; Guimarães PO; Mehran R; Windecker S; Valgimigli M; Angiolillo DJ; Bhatt DL; Sandoval Y; Chen SL; Stone GW; Lopes RD
    JAMA Cardiol; 2024 Dec; 9(12):1094-1105. PubMed ID: 39382876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.